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Tryptophan hydroxylase 2 (TPH2) catalyses the initial and rate-limiting
step in the biosynthesis of serotonin, which is associated with a variety of
disorders such as depression, obsessive compulsive disorder, and
schizophrenia. Full-length TPH2 is poorly characterized due to low purifi-
cation quantities caused by its inherent instability. Three truncated variants
of human TPH2 (rchTPH2; regulatory and catalytic domain, ND47-
rchTPH2; truncation of 47 residues in the N terminus of rchTPH2, and
chTPH2; catalytic domain) were expressed, purified, and examined for
changes in transition temperature, inactivation rate, and oligomeric state.
chTPH2 displayed 14- and 11-fold higher half-lives compared to rchTPH2
and ND47-rchTPH2, respectively. Differential scanning calorimetry experi-
ments demonstrated that this is caused by premature unfolding of the less
stable regulatory domain. By differential scanning fluorimetry, the unfold-
ing transitions of rchTPH2 and ND47-rchTPH2 are found to shift from
polyphasic to apparent two-state by the addition of L-Trp or L-Phe. Ana-
lytical gel filtration revealed that rchTPH2 and ND47-rchTPH2 reside in a
monomer–dimer equilibrium which is significantly shifted toward dimer in
the presence of L-Phe. The dimerizing effect induced by L-Phe is accompa-
nied by a stabilizing effect, which resulted in a threefold increase in half-
lives of rchTPH2 and ND47-rchTPH2. Addition of L-Phe to the purifica-
tion buffer significantly increases the purification yields, which will facili-
tate characterization of hTPH2.
Tryptophan hydroxylase (TPH) catalyses the rate-lim-
iting reaction in the biosynthesis of the hormone and
neurotransmitter serotonin (5-HT). TPH uses the
cofactor Fe2+ and the cosubstrates O2 and tetrahydro-
biopterin (BH4) to generate 5-hydroxytryptophan (5-
HTP) by hydroxylation of L-tryptophan (L-Trp).
5-HTP is enzymatically converted to 5-HT by aromatic
amino acid decarboxylase [1,2]. TPH exists in two
isoforms, where isoform 1 (TPH1) is mainly responsi-
ble for catalyzing the rate-limiting step in the biosyn-
thesis of peripheral serotonin, and isoform 2 (TPH2)
primarily is associated with the biosynthesis of neu-
ronal serotonin [1]. The regulation of serotonin levels
is involved in various physiological and psychiatric dis-
orders such as irritable bowel syndrome, depression,
obsessive compulsive disorder, and schizophrenia [3].
Abbreviations
5-HT, 5-hydroxytryptamin (serotonin); 5-HTP, 5-hydroxytryptophan; AAAH, aromatic amino acid hydroxylase; ACT, aspartate kinase,
chorismate mutase and TyrA; BH4, tetrahydrobiopterin; chTPH2, catalytic domain of human tryptophan hydroxylase; DSC, differential
scanning calorimetry; DSF, differential scanning fluorimetry; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; L-Phe, L-
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Of these, depression is associated with decreased levels
of neuronal serotonin, whereas some gastrointestinal
disorders are associated with increased peripheral sero-
tonin levels [4–6]. The serotonergic systems are there-
fore important targets in treatment of these disorders
[7], which makes both TPH isoforms important
enzymes to characterize.
Along with phenylalanine hydroxylase (PAH) and
tyrosine hydroxylase (TH), TPH forms an enzyme sub-
family of iron(II)-containing mono-oxygenases collec-
tively referred to as the aromatic amino acid
hydroxylases (AAAHs). Various truncated variants of
all three AAAHs have been structurally characterized
[8–12]. For hTPH, the catalytic cores of both isoforms
have been structurally and enzymatically characterized
[13–15] due to successful purification strategies [16,17].
All enzymes in the AAAH family form tetramers
through dimers of dimers [18]. Each monomeric sub-
unit consists of an N-terminal regulatory domain, a
highly conserved catalytic domain, and a C-terminal
tetramerization domain [19]. The N-terminal domains
of PAH and TH contain a characteristic ACT fold
motif [12,20]. From sequence analysis, TPH has also
been proposed to contain an ACT domain [21]. Trun-
cations of the regulatory domains have been found not
to change the tetrameric assembly of TPH1 or TPH2
[1,22]. In contrast, when the C-terminal tetrameriza-
tion domain is also removed, monomeric species are
observed [1]. Deletions from the C-terminal domain of
rabbit TPH1 have been demonstrated to change the
macromolecular structure from a tetramer to predomi-
nantly monomeric form without compromising cat-
alytic activity [23,24].
The available crystal structures of TPH1 only com-
prise the catalytic domain, while the crystal structure
of TPH2 includes both the catalytic and the tetramer-
ization domains [13,14,25–27]. The lack of structural
information of the regulatory domain is partly due to
the great instability of full-length TPH [16,28]. In
TPH, the regulatory domain, in particular, has been
found to cause instability and therefore limiting the
quantities purified from Escherichia coli expression sys-
tems [1,16]. The regulatory domain of TPH2 has an
additional 46 residues compared to TPH1, which are
partly responsible for the limited purification quanti-
ties [29]. The fundamental role of the regulatory
domain and the additional residues in the terminus is,
however, poorly understood, as characterization is
hampered by the limited purification yields. Therefore,
structural insight is obtained from the crystal structure
of rat phenylalanine hydroxylase (rnPAH) (PDB ID:
1PHZ – Clustal Omega: 35% sequence identity in the
regulatory domain and 57% total sequence identity)
which comprises the catalytic and the regulatory
domains. This structure lacks interpretable electron
density in the first 18 residues of the N terminus, sug-
gesting that this region is flexible [20]. The flexibility of
the N terminus has also been confirmed by an NMR
study [30]. By alignment of the sequences of rnPAH
and hTPH2 (Fig. S1), it is found that residues 20 to 47
of hTPH2 align with the mobile 18 residues of rnPAH,
which suggests that these residues of hTPH2 are
mobile and might cause instability and insolubility.
Therefore, an ND47-rchTPH2 variant was expressed,
purified, and characterized.
The current study sheds light on the influence of the
regulatory domain on macromolecular structure and
stability of TPH2 by characterizing three truncated
variants (sequences shown in Supporting information);
chTPH2 (catalytic domain), rchTPH2 (regulatory and
catalytic domains), and ND47-rchTPH2 (47 residue
truncation in the N-terminal domain). The tetramer-
ization domain (residue 460–490) was removed to
investigate the role of the regulatory domain when
TPH2 was not in a tetramer. As TPH2 is poorly char-
acterized due to low stability, additional efforts were
made to identify ligands that could increase the stabil-
ity, and hence purification yield, of TPH2.
Results and Discussion
Differential scanning fluorimetry
Very little is known about the regulation and structure
of TPH as purification of this enzyme results in limited
quantities. The presence of the regulatory domain is
known to cause low stability and solubility [1]. To
overcome this problem, substrates for the AAAH fam-
ily (L-phenylalanine, L-tryptophan, and L-tyrosine),
other ligands known to bind certain ACT domains (L-
valine [31] and L-serine [32]), as well as D-phenylala-
nine, 5-HTP, and 5-HT were assayed for changes in
the thermal unfolding of the TPH2 variants. The
ligands were screened in a broad concentration range
(0.1 lM–10 mM). For chTPH2, an almost ideal two-
state unfolding behavior was observed, Fig. 1. All
ligands, except 5-HTP and 5-HT, were found to have
no significant effect on the unfolding or Tm value of
chTPH2, Fig. 1. 5-HTP and 5-HT appear to change
the unfolding of chTPH2 from two-state to continu-
ous; hence, no Tm values could be obtained at high
ligand concentration.
Containing the regulatory domain, rchTPH2, gave
rise to inconsistent and polyphasic unfolding curves
from which no Tm values could be obtained (Fig. S2).
The ligand screen showed that L-Trp and L-Phe induced
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unfolding transitions with apparent two-state unfolding
in a concentration-dependent manner (Fig. 2), which
were accompanied by an increase in transition tempera-
tures. The apparent two-state unfolding was gradually
acquired with increasing ligand concentration, and
robust apparent two-state unfolding was obtained at L-
Trp (Fig. 2A) and L-Phe (Fig. 2C) concentrations of
1.0 mM and 3.0 mM, respectively. At 0.1 mM L-Trp,
rchTPH2 displayed a transition temperature of
46.3  1.4 °C. This was increased to 52.4  0.7 °C by
the addition of 10.0 mM L-Trp. The exponential fit in
Fig. 2B shows that saturation has been reached at
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Fig. 2. Representative baseline corrected
differential scanning calorimetry curves of
rchTPH2 or ND47-rchTPH2 (1 lM). (A) DSF
curves of rchTPH2 with different L-Trp
concentration. (B) Tm values with
increasing L-Trp concentration for rchTPH2
with an exponential fit. (C) DSF curves of
rchTPH2 with different L-Phe
concentration. (D) Tm values with
increasing L-Phe concentration for rchTPH2
with an exponential fit. (E) DSF of ND47-
rchTPH2 curves in the absence of ligand,
presence of 10 mM L-Phe, or presence of
10 mM L-Trp.
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10 mM L-Trp. The transition temperature of rchTPH2
was increased from 48.2  1.9 to 51.0  0.9 °C by
increasing the L-Phe concentration from 1.0 mM to
10.0 mM (Fig. 2D). Similarly, a study by Gersting et al.
[33] utilizing differential scanning fluorimetry (DSF)
found that 1 mM L-Phe increases the transition tempera-
ture of PAH from 47.5 to 50.9 °C. None of the other
ligands, including D-Phe, were able to induce this change
in unfolding (data not shown). The same stabilizing
trend for L-Phe and L-Trp was observed for ND47-
rchTPH2, Fig. 2E.
As both L-Trp and L-Phe gave rise to increased tran-
sition temperatures, a combination of the compounds
was analyzed. Figure 3 shows that increasing the con-
centration of either L-Trp or L-Phe in the presence of
the other compound results in increased Tm values,
suggesting that L-Trp and L-Phe are able to increase
the transition temperature in an additive fashion. The
additive effect is supported by the increase in Tm val-
ues with increasing L-Phe concentration observed at
saturated concentration of L-Trp (10 mM in Fig. 3).
Analytical gel filtration
It has previously been shown in DSF assays that under
stabilizing conditions multi-component complexes can
change from polyphasic to almost two-state unfolding
and that this is indicative of monodispersity and stabil-
ity [34]. This was investigated in the case of L-Phe and
L-Trp as unfolding of rchTPH2 and ND47-rchTPH2
was shifted toward two-state with the addition of these
compounds. The oligomeric states of the TPH2 vari-
ants were analyzed utilizing analytical size exclusion
chromatography (SEC). In consensus with the findings
of D’Sa et al. [22], chTPH2 was found to elute at a
volume corresponding to the molecular weight of a
monomer (36.2 kDa) [35]. In the loading concentration
range of 2 to 60 lM, chTPH2 was found only to reside
as a monomer, Fig. 4. Additionally, 3 mM L-Phe did
not induce any change in the elution pattern of the
monodisperse solution complementing the observations
from the DSF experiments.
A study by Mockus et al. [23] on rabbit TPH1 has
demonstrated that truncation of the C-terminal
tetramerization domain resulted in a disruption of the
tetrameric assembly. This was also found to be the
case for hTPH2, as SEC of ND47-rchTPH2 yielded
two overlapping peaks with elution volumes corre-
sponding to molecular weights of a monomer
(47.4 kDa) and a dimer (94.9 kDa) (Fig. 5). The grad-
ual shift of the elution peaks from a monomer to a
dimer shows that ND47-rchTPH2 is found to be in a
concentration-dependent monomer–dimer equilibrium.
Within experimental error, the peak widths at half
height were constant over the range of TPH
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Fig. 3. Transition temperatures (n = 3–4) obtained from DSF
experiments of rchTPH2 with the addition of L-Trp and L-Phe.
Average standard deviation in each point is 0.8 °C. Curves
represent exponential fit of Tm values as a function of [L-Phe] at
constant [L-Trp]. Data for the lowest concentration of L-Phe at
10 mM L-Trp were omitted from the fit.
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Fig. 4. Size exclusion chromatography of
chTPH2 with no ligand (black lines) and
with the addition of 3 mM L-phenylalanine
(orange lines). The markers (▲) indicate
the expected elution volumes of a dimer
and a monomer, respectively. Protein
loading concentrations are indicated in the
chromatograms. (A) High loading
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concentrations, and the peak heights were also found
to be related directly to the concentration of TPH
injected. The dilution factor was found to be
1.90  0.13 and constant within the elution range of
the TPH variants. From the SEC results, the equilib-
rium constant, Kd, of the dissociation of a dimer into
monomers was calculated (equation (7) in Materials
and methods). A Kd value of 1.3  0.1 lM was found
based on the six concentrations of ND47-rchTPH2 in
the absence of L-Phe. This value is lower than the dis-
sociation constant of 46  35 lM determined for the
dimerization of the regulatory domain of PAH [36]. A
plot of fraction dimer, fD, as a function of ND47-
rchTPH2 concentration gave a hyperbolic-like curve as
expected for a monomer–dimer equilibrium, Fig. 6.
The difference in oligomeric states of chTPH2 and
rchTPH2/ND47-rchTPH2 shows that dimerization is
caused by the regulatory domain. This finding is sup-
ported by a model structure proposed by Jiang et al.
[37] in which the regulatory domain of one monomer
forms intersubunit interactions to an adjacent mono-
mer. The involvement of the regulatory domain in
structural assembly is further supported by results
from Yohrling et al. [38] on rabbit TPH1, where ND41
and ND90 truncations resulted in monomers indicating
that the regulatory domain is involved in the forma-
tion of the tetrameric assembly. D’Sa et al. [22], how-
ever, found that the tetrameric assembly was retained
upon truncation of the regulatory domain of human
TPH2. Collectively, this might suggest that both the
C-terminal tetramerization domain and the N-terminal
regulatory domain contribute to the formation of a
stable tetramer.
The effect of L-Phe on the monomer–dimer
equilibrium was analyzed by performing SEC on
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ND47-rchTPH2 samples with and without the addition
of L-Phe. In Fig. 5, the black curves represent elution
of ND47-rchTPH2 without the addition of L-Phe, and
the orange curves represent the elution of protein
when the sample and running buffer contained 3 mM
L-Phe. It is evident that L-Phe shifts the equilibrium
toward dimer. At a loading concentration of 2 lM
ND47-rchTPH2, the addition of L-Phe was found to
shift the equilibrium from predominately monomer to
almost exclusively dimer. The same shift in monomer–
dimer equilibrium was observed for rchTPH2
(Fig. 7A). This result correlates well with the observa-
tions in the DSF experiments, where the unfolding
curves change from polyphasic toward two-state with
the addition of L-Phe.
The influence of L-Trp and D-Phe on the monomer–
dimer equilibrium was additionally analyzed to investi-
gate the specificity of L-Phe. Figure 5C,D shows the
monomer–dimer distribution of ND47-rchTPH2 with
0.5 mM L-Trp or 3 mM D-Phe in a protein concentra-
tions range from 2 to 60 lM. From the SEC results in
Fig. 5, dimerization Kd values of 1.6  0.7 lM and
1.8  0.9 lM were determined in the presence of L-Trp
and D-Phe, respectively. 3 mM D-Phe or 0.5 mM L-Trp
does, therefore, not change the monomer–dimer equi-
librium constant. At a TPH2 loading concentration of
2 lM, it is evident by comparison of Fig. 5B,D that
neither the addition of 0.5 mM L-Trp nor 3 mM D-Phe
induced the shift in the monomer–dimer equilibrium
toward dimer as observed for L-Phe. L-Trp absorption
introduced high background noise and was hence only
added to concentrations of 0.5 and 1.0 mM. As a con-
sequence of the background noise, chromatograms of
ND47-rchTPH2 with loading concentrations below
5 lM could not be obtained at 1.0 mM L-Trp. How-
ever, at low protein concentrations (5–20 lM), the
monomer–dimer equilibrium does not seem to be influ-
enced by 1.0 mM L-Trp as monomer is present
(Fig. 7B), which is not observed in the presence of L-
Phe (Fig. 5A,B). The addition of 1 mM L-Trp is
compared with 3 mM L-Phe as these concentrations
were found in the DSF experiments to change the
unfolding from polyphasic to apparent two-state
(Fig. 2A,C). The fact that L-Trp did not induce the
same shift in equilibrium suggests that the stabilization
observed in the DSF experiments occurs through a dif-
ferent mechanism than for L-Phe. Furthermore, L-Phe
binding is found to be specific as D-Phe did not induce
dimerization. That L-Trp does not induce dimerization
in rchTPH2 extends recent results obtained by Patel
et al., who showed that among the regulatory domains
of TH, PAH, and TPH1, only PAH dimerizes in the
presence of its natural substrate [39].
Thermal inactivation
To investigate if the dimerizing effect had an impact on
TPH2 stability, rates of inactivation at 30 °C in the
presence or absence of 3 mM L-Phe were examined. The
data were fitted with one-exponential decay curves, and
the rate constants, k, were calculated using an exponen-
tial function, Et = E0e
kt, where E0 is the initial enzyme
activity, and Et is the activity after time t at 30 °C
(Fig. 8). From the decay rate constants, half-lives (t½)
of the hTPH2 variants were calculated using t½ = ln(2)/
k. At 30 °C and a concentration of 5 lM, rchTPH2, and
ND47-rchTPH2 displayed t½ values of only 15  2 and
18  3 min, respectively. Hence, truncation of the N
terminus slightly increased the t½ value (P = 0.18, T-
test). With a t½ value of 203  40 min, chTPH2 dis-
played a 14-fold higher half-life compared to rchTPH2,
which is in agreement with the results of Carkaci-Salli
et al. [1] and confirms that the presence of the regula-
tory domain causes significant destabilization. With
addition of 3 mM L-Phe, t½ values of 41  3, 49  5,
and 193  29 min were obtained for rchTPH2, ND47-
rchTPH2, and chTPH2, respectively. Variants contain-
ing the regulatory domain displayed nearly 3-fold
increase in half-lives whereas chTPH2 was not signifi-
cantly influenced by L-Phe.
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That the stabilizing effect is exclusively observed for
rchTPH2 and ND47-rchTPH2 implies that L-Phe is sta-
bilizing through binding to the regulatory domain.
Further, as L-Phe induces a stabilizing effect in both
rchTPH2 and ND47-rchTPH2, binding of L-Phe does
not seem to involve the 47 N-terminal residues. L-Phe
induced stability and shift in equilibrium toward dimer
imply that TPH2 variants containing the regulatory
domain are more stable as dimers.
A stabilizing effect of L-Trp has previously been
observed by McKinney et al. [16] who hypothesized
that L-Trp might stabilize through binding in the
active site, which might tighten up flexible regions, and
hereby protect the active site. The increase in Tm
(DSF) upon the addition of L-Phe or L-Trp might,
analogously to the hypothesis of McKinney et al. [16],
occur through binding in the active site which in turn
induces a more closed conformation, as it has been
seen for binding of tryptophan in chicken TPH [25].
However, a shift in the monomer–dimer equilibrium is
only observed for L-Phe, suggesting that the increase
in Tm and half-life occur through different mecha-
nisms. Alternatively, L-Phe binds in an allosteric site
which stabilizes the regulatory domain through
improved interactions with an adjacent monomer.
Such an allosteric site in the regulatory domain has
been identified in PAH, which has been found to
increase PAH activity and stability and induce large
conformational changes [20,39–41]. This is consistent
with the binding of amino acids to ACT domains
which often occurs at domain interfaces and results in
conformational changes [42]. This hypothesis is sup-
ported by the observed shift in monomer–dimer equi-
librium and the additive effect of L-Trp and L-Phe
observed in the DSF experiments. Such an allosteric
site might have relevance in vivo functioning as an
allosteric modulating site that stabilizes a dimer in the
native tetramer (dimer of dimers). Stabilization of the
tetramer is important as disruption of the native tetra-
mer results in decreased enzymatic activity [43].
Differential scanning calorimetry
The transition temperatures, Tm, of the TPH2 variants
were measured utilizing differential scanning calorime-
try (DSC), to investigate if the low half-life of
rchTPH2 is caused by premature unfolding of the reg-
ulatory domain. The DSC experiments were performed
in the presence of L-Phe to observe domain unfolding
in a monodisperse solution. All variants displayed irre-
versible unfolding upon reheating and hence, only Tm
values were extracted from the thermograms. Illustra-
tive examples of DSC thermograms of the three vari-
ants are presented in Fig. 9.
The unfolding transitions of the three variants seem
equivalent, however, by comparison of the thermo-
grams of chTPH2 and ND47-rchTPH2 (Fig. 9A,B), it
is evident that truncation of the regulatory domain
resulted in a reduction in the heat capacity of the low
temperature transition (Tm(low)). This suggests that
the lowest temperature transitions are partly due to
the unfolding of the regulatory domain, as suggested
for hPAH by Thorolfsson et al. [44]. The remaining
transitions, therefore, originate from the unfolding of
the more stable catalytic domain, quantified by the
transition temperature of the main peak in the thermo-
grams (Tm(high)). Transition temperatures obtained
from the thermograms are presented in Table 1.
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Deletion of the regulatory domain increased the Tm
values of the two main transitions by 1.6 and 2.9 °C,
respectively. Truncation of the N terminus only
induced a slight increase in the Tm(high) value
(P = 0.053, T-test).
The regulatory and catalytic domains of rchTPH2
unfold at 40.1  1.2 °C and 46.8  0.3 °C, respec-
tively. These results are, despite variations in the buf-
fer systems, in the same range as previously reported
transition temperatures for AAAHs (47.5–55.5 °C)
[33,45,46]. The DSC data relate to the inactivation
measurements, as unfolding of the variants containing
the regulatory domain is initiated at around 30 °C
(Fig. 9C,B), which is the temperature of the inactiva-
tion measurements, and around 35 °C for chTPH2
(Fig. 9A). This might explain the significantly higher
t½ values observed for chTPH2 at 30 °C. Unfolding of
rchTPH2 shows a less profound low temperature tran-
sition compared to ND47-rchTPH2. This might be
explained by the mobile N terminus causing a less
defined regulatory domain which seems to unfold more
continuously initiated at lower temperature than
observed for chTPH2. Furthermore, the presence of
the regulatory domain causes an earlier unfolding of
the catalytic domain; this signifies that attempts to sta-
bilize TPH should occur through the regulatory
domain.
Purification yield
Characterization of hTPH2 variants containing the
regulatory domain has been hampered by the low
quantities obtained from E. coli, partially due to the
poor stability. Figure 10 presents the purification
yields obtained for the three variants with and without
L-Phe added to the purification buffer. Without L-Phe,
very low purification quantities were obtained for
rchTPH2 (0.9  0.2 mgL1) compared to chTPH2
(12.0  2.4 mgL1). The low quantities for rchTPH2
were overcome by truncation of the N terminus which
resulted in an 11-fold increase in yield
(10.4  3.1 mgL1), which was similar to that of
chTPH2.
The stabilizing effect of L-Phe was reflected in the
purification yields, as they were increased seven- and
twofold for rchTPH2 (6.4  1.2 mgL1) and ND47-
rchTPH2 (25.1  2.9 mgL1), respectively (Fig. 10).
In line with the results observed in the inactivation
experiment, no significant change in purification yield
was observed for chTPH2 (9.9  3.1 mgL1).
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Table 1. The transition temperature of the investigated hTPH2
variants obtained from DSC, where means  SD of Tm(low) and
Tm(high) values (Fig. 9) obtained from three independent
experiments are listed. A protein concentration of 35 lM was used
in all measurements.
rchTPH2 ND47-rchTPH2 chTPH2
Tm(low), °C 40.1  1.2 39.6  0.5 41.7  0.4
Tm(high), °C 46.8  0.3 47.7  0.5 49.7  0.1
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Fig. 10. Purification yields (mgL1 cell culture, n = 2–6) of the
three hTPH2 variants (mean  SD). Orange and dark gray bars
state yields obtained from purifications using Phe buffer (20 mM
HEPES/NH4OH, 300 mM (NH4)2SO4, pH 7.0, and 3 mM L-Phe) and
Std buffer (20 mM HEPES/NH4OH, 300 mM (NH4)2SO4, and pH
7.0), respectively.
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Conclusion
The current results demonstrate that L-Trp and L-Phe
change the unfolding mechanism of hTPH2, but only
when the regulatory domain is present. Deletion of the
C-terminal tetramerization domain results in a
monomer–dimer equilibrium which is shifted to pre-
dominately dimer with the addition of L-Phe. In the
presence of L-Phe, the dimer displayed significantly
increased half-life which in turn resulted in signifi-
cantly increased purification yields of hTPH2 variants
containing the regulatory domain. These findings will
facilitate future characterization of hTPH2.
Materials and methods
Materials
All used chemicals were of analytical grade, and all solutions
were prepared using water from an 18.2 MΩcm Milli-Q syn-
thesis A10 Q-Gard system which was filtered through a 0.22-
lm filter. Protein purification was performed on an €AKTA
purifier 100 from GE Healthcare. Utilized GE Healthcare col-
umn variants: HiLoad Superdex 200 26/60 pg, Superdex 200
10/300 GL, and a XK 16/20 column packed with 25 mL Dex-
trin Sepharose High Performance media. During purifications,
all TPH-containing solutions were kept in ice water, except
during the chromatographic steps, which were performed at
room temperature. Protein solutions were concentrated using
an Amicon ultrafiltration cell with an Ultracell PL-3 mem-
brane. Protein concentrations were determined by measuring
the absorbance at 280 nm on an ND-1000 NanoDrop Spec-
trophotometer from Saveen Werner (Limhamn, Sweden).
Cloning and expression
Full-length human TPH2 cDNA optimized for expression in
E. coli was obtained from GenScript (Piscataway, NJ, USA).
All proteins were expressed as maltose binding protein fusion
proteins from the pET26 expression vector in E. coli BL21
(DE3) (Novagen, Merck Millipore, Darmstadt, Germany)
cells. The sequences of the proteins expressed are given in the
Supporting information. The recombinant fusion proteins
contain a cleavage recognition site for human rhinovirus 3C
protease (3CP) [47]. The construct encoding the different
protein variants was obtained by PCR. The primers used are
listed in Table S1. All DNA sequences were verified by
sequencing (Eurofins). Proteins were expressed at 20 °C for
14 h, as previously described [17]. MBP-3CP was cloned and
expressed in-house in a similar manner.
Purification
Escherichia coli cells from 650 mL cultures were thawed
from 80 °C and resuspended in buffer containing 20 mM
HEPES/NH4OH, 300 mM (NH4)2SO4, pH 7.0 (standard
buffer, Std buffer) or 20 mM HEPES/NH4OH, 300 mM
(NH4)2SO4, pH 7.0, and 3 mM L-Phe (Phe buffer), to a vol-
ume of 40 mL. (NH4)2SO4 was included in the purification
buffer, as it has been found that the purification yield of
recombinant catalytic core of rabbit TPH1 was enhanced
by the addition of ammonium sulfate [24]. The resuspended
cell culture was lysed by sonication for 3 9 30 s using a
Satorius Labsonic at 80% amplitude, while kept in ice
water. The lysed sample was centrifuged at 4 °C and
18 000 g for 20 min. The supernatant was decanted to
another tube and centrifuged a second time at 4 °C and
18 000 g for 20 min, while the pellet was discarded. The
supernatant was collected and filtered through a 0.45-lm
filter. A volume of approximately 35 mL filtered super-
natant was loaded with a flow rate of 5 mLmin1 onto a
Dextrin Sepharose column, which was equilibrated with
five column volumes of Std or Phe buffer. Following sam-
ple loading, an MBP-3CP solution was prepared by dilut-
ing MBP-3CP from stock with Std or Phe buffer to a
concentration of 2.2 lM. About 30-mL MBP-3CP solution
was loaded onto the column with a flow rate of
5 mLmin1, and the column was incubated at room tem-
perature for 1 h. Once the flow (5 mLmin1) was resumed,
10 mL of the protein-containing eluate was collected. The
collected solution, containing target protein, was filtered
through a 0.45-lm filter prior to loading on a HiLoad
Superdex 200 prep grade column, which had been equili-
brated with two column volumes of Std or Phe buffer. Std
or Phe buffer was used as mobile phase using a flow rate
of 2.5 mLmin1, and UV-detected (280 nm) peaks contain-
ing the target protein (verified by SDS/PAGE analysis –
Figs S3–S5) were collected. The concentration of the col-
lected protein was determined by UV-Vis absorption at
280 nm utilizing theoretical extinction coefficients obtained
from Expasy [48]. The samples were either concentrated by
ultrafiltration prior to freezing in liquid nitrogen, or if the
concentration of target protein was high enough in the elu-
ate, the ultrafiltration was bypassed, and the protein solu-
tion was frozen in liquid nitrogen and stored at 80 °C.
SDS/PAGE
Evaluation of molecular weights and purity were conducted
by SDS/PAGE. Proteins were resolved on Mini-PRO-
TEAN TGX gels (7.5%) from Bio-Rad (Hercules, CA,
USA) run at 100 V for 75 min with a protein standard
from Bio-Rad (no. 161-0304). Gels were stained with Coo-
massie Blue to visualize the proteins.
Differential scanning fluorimetry
The unfolding of the TPH2 variants was recorded with an
Agilent Technologies Stratagene MX3005 P RT-PCR
machine (Santa Clara, CA, USA). The ligand screen was
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performed with a total volume of 25 lL in 96-well plates
(polypropylene plates from Agilent Technologies). Each well
was composed of protein at a concentration of 1 lM, SYPRO
orange at a concentration of 29 (diluted from SYPRO
50009 stock from Sigma, St. Louis, MO, USA), and ligand
(diluted in purification buffer) in a concentration range of
0.1 lM to 10 mM. Each plate contained control wells with the
purification buffer with and without protein and ligand.
Scans were carried out using a scan rate of 1 °Cmin1, going
from 20 °C to 95 °C. The thermograms were baseline cor-
rected with MXPRO QPCR Software (Agilent Technologies,
Santa Clara, CA, USA) and analyzed for transition tempera-
tures with GRAPHPAD PRISM 6 (GraphPad Software, Inc, La
Jolla, CA, USA) utilizing a Boltzmann sigmoid fit:
y ¼ LLþ UL LL
1þ exp Tmxa
 
where LL and UL are the values of minimum and maximum
intensities, respectively, and a denotes the slope of the unfold-
ing curve at Tm [49].
Analytical size exclusion chromatography
Determination of the oligomeric state of the TPH2 variants
was performed on a Superdex 200 10/300 GL column.
Prior to analysis, the column was equilibrated with two col-
umn volumes of the buffer of investigation, and the sam-
ples were spiked with concentrated stock solutions of L-
Trp, L-Phe, or D-Phe and allowed to equilibrate for 20 min.
Samples were injected with a 500 lL loop and analyzed at
a flow rate of 0.5 mLmin1. Calibration curve of molecu-
lar weights was obtained from GE Healthcare [35].
The equilibrium constant of the dissociation of a dimer
into monomers was based on the scheme below
D!Kd MþM
The equilibrium dissociation constant, Kd, is defined by
Kd ¼ ½M
2
½D ð1Þ
where [M] and [D] are the molar concentrations of mono-
mer and dimer, respectively. The total protein concentra-
tion, [M]total, can be expressed in terms of molar monomer
equivalents
½Mtotal ¼ ½M þ 2½D ð2Þ
and the concentration of dimer is therefore given by
½D ¼ ½Mtotal  ½M
2
ð3Þ
Under the assumptions that e280,dimer = 2e280,monomer and
area under the size exclusion curve (SEC) curve (AUC) /
[M], the molecular concentration of monomer is given by
½M ¼ AUCM
AUCM þAUCD ½Mtotal ð4Þ
where AUCM and AUCD are the area under the curve of
the peaks representing the monomer and dimer, respec-
tively, obtained by deconvolution of the chromatograms
from the SEC experiments. Substituting [M] in equation (3)
by the expression of [M] in equation (4) yields
½D ¼ 1
2
AUCD
AUCM þAUCD ½Mtotal ð5Þ
where AUCD/(AUCM + AUCD) is the mole fraction of
dimer, fD. Substituting [M] and [D] from equation (4) and
(5), respectively, into equation (1) yields
Kd ¼ 2AUC
2
M½Mtotal
AUCDðAUCD þAUCMÞ ð6Þ
The sample concentration loaded in SEC will be diluted
during separation. Therefore, when applying equation (6),
[M]total must be divided by the dilution factor, DF, intro-
duced during gel filtration
Kd ¼
2AUC2M
[M]total
DF
AUCDðAUCD þAUCMÞ ð7Þ
The dilution factor during elution was measured by the
width at half height of the peak divided by the sample load
volume [50]. This was performed only on monodisperse
solutions. The fraction of dimer, fD, as a function of
[M]total can be expressed as
½D ¼ 1
2
fD
½Mtotal
DF
ð8Þ
½M ¼ ð1 fDÞ
Mtotal
DF
ð9Þ
Substituting [M] and [D] from equation (8) and (9), respec-
tively, into equation (1) yields
Kd ¼
ð1 fDÞ
Mtotal
DF
 2
fD 12 
Mtotal
DF
ð10Þ
Solving equation (10) for the fraction of dimer, fD, yields
fD ¼
1
4 4
[M]total
DF
þ Kd  1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
K2d þ 8Kd
[M]total
DF
r !
[M]total
DF
ð11Þ
Activity assay
The activity measurements were performed using a Varian
Cary Eclipse Fluorescence Spectrophotometer. For activity
measurements, the hTPH2 variants were thawed under
running water, filtered, and the concentrations were
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determined by UV-Vis absorption at 280 nm. The hTPH2
samples were diluted to a protein concentration of 5 lM in
the buffer in which it was purified. TPH2 activity was
assayed in a reaction mixture (10 9 10 mm QS quartz cuv-
ette from Hellma (Mu¨llheim, Germany) – 2500 lL total
volume) containing 50 mM HEPES/NH4OH, 200 mM
(NH4)2SO4, pH 7.0, 0.025 gL1 catalase, 25 lM (NH4)2Fe
(II)(SO4)2
.6H2O, 7 mM dithiothreitol (DTT), 60 lM L-Trp,
and 300 lM BH4 with stirring at 15 °C [14,51]. The excita-
tion wavelength was 300 nm, and the emission was moni-
tored at 330 nm. The activities were determined by the
initial slope (intensitymin1) of the monitored fluorescence
and were quantified using VARIAN SPECTROPHOTOMETER soft-
ware (Agilent Technologies). Quantification occurred
through linear regression on a manually placed interval of
minimum 0.04 min of the initial curve. Denaturation was
performed by heating the protein in aliquots of 1300 lL to
30 °C in a water bath. The denaturation was stopped by
cooling the protein solution in ice water.
Differential scanning calorimetry
Differential scanning calorimetry (DSC) measurements
were carried out on a TA Instruments (New Castle, DE,
USA) 6300 Nano DSC. Solutions of protein in L-Phe con-
taining buffer were used for sample measurements, and the
same buffer as used in the purification of the hTPH2 vari-
ants were used as references. Prior to sample loading, the
protein sample and the reference buffer were degassed at
approximately 10 °C using a MicroCal (MicroCal, LLC,
Northhampton, MA, USA) USB ThermoVac. Three hun-
dred microliters of protein sample and reference buffer
were loaded in the respective cells. A constant pressure of
3 atm was applied, and scans were carried out using a scan
rate of 1 °Cmin1, going from 5 °C to 70 °C. Deconvolu-
tion of the thermograms was performed with Peakfit v4.12
using Gaussian peak functions.
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